The drug regulator's advisory body in Europe has recently recommended to approve legal distribution of a generic version of the worldwide impotence drug by Pfizer Pharmaceutical Company: Viagra.

This Generic Viagra alternative has gained positive reviews from the European Medicine Agency's Committee for Medical Products for Human Use, after German generic producer Ratiopharm presented their version of Viagra. Commentaries by this institution will help to create a friendlier panorama on the final approval by the European Commission.

Pfizer authorities said that Viagra has patent protection in Europe until 2013, whereas the US market patent expires in 2012. Sales reports on Viagra show that this blue magic pill sold $1.3 billion around the world in the first nine months of 2009 alone. Now, thanks to the marketing potential and the future approval of Generic Viagra, many other generic manufacturing companies will soon be offering a new way to purchase the drug. Some already refer to it as Viagra Online.

It is still unknown if Ratiopharm plans to launch their generic version of Viagra before the patent expires. However, it will become evident that other manufacturers that are also trying to place Generic Cialis, Generic Viagra and Generic Levitra in the market, are the ones behind the final resolution of this old dispute. It is precisely, the manufactures of Cialis, Eli Lilly & Co., that recently gained a positive feedback from the European Committee for pulmonary arterial hypertension drug Adcirca. Adcirca contains the exact same ingredients as Lilly's Cialis, an ED medication that competes with Pfizer's Viagra.

Moreover, the U.S. Food and Drug Administration has already approved Adcirca in the U.S., marketed by United Therapeutics Corp. As a consequence, it is a matter of time for Generic Viagra and other impotence drugs to make their legal way into U.S. and Canadian markets. In fact, it is Canadians who are more ahead in this battle, since earlier this year Teva Pharmaceutical Industries Ltd., almost managed to sell a Generic Viagra version in this country. This attempt was only block by Pfizer's negative response, and the courts final blocking of the proposal.